Diquafosol Tetrasodium api
211427-08-6
Pharmaceutical Grade
99%
Shanghai
25kg/Cardboard Drum
2023-05-25
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Uridine(5')tetraphospho(5')uridine tetrasodium salt
Other Name:diquafosol;INS 365;INS-365;INS365;Diquafosol tetrasodium;Ins 365;Up4U;UNII-X8T9SBH9LL;X8T9SBH9LL;INS365;KPY-998;DE-089;211427-08-6;Diquafosol sodium;Diquafosol tetrasodium (USAN);Diquafosol tetrasodium [USAN];Diquafosol (tetrasodium);CHEMBL1767408;tetrasodium;[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;Prolacria;Diquas;Diquafosol sodium (JAN);Diquafosol tetrasodium salt;INS365 Ophthalmic Solution;U2P4;Uridine 5'-(pentahydrogen tetraphosphate), P'''-5'ester with uridine, tetrasodium salt;D03864;P1,P4-Diuridine 5'-tetraphosphate tetrasodium salt;Uridine(5')tetraphospho(5')uridine tetrasodium salt;Q27293698;Uridine, 5'-(pentahydrogen tetraphosphate), P'''-5'-ester with uridine, tetrasodium salt
CAS No.:211427-08-6
Molecular Formula:C18H22N4Na4O23P4
InChIKeys:OWTGMPPCCUSXIP-FNXFGIETSA-J
Molecular Weight:878.2 g/mol
Exact Mass:877.9216081 g/mol
UNII:X8T9SBH9LL
Categories:
Characteristics-
PSA:
405 Ų
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Location:
Building 4, Juanhu Int. Sci & Innovation Park, No. 500, Shuiyueting East Road, Xishi Street, Haining, Jiaxing, Zhejiang
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
20
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
201-300
-
Year of Establishment:
2021
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product